PASG Passage Bio, Inc. - Common Stock
$4,56
Precio · Ago 19, 2026
Fundamentales a fecha de Ago 10, 2026
Rango 52S
$3–$20
8% of range
Calificación del Analista
BUY
9 analysts
Precio Objetivo
$16
+240% upside
P/E (TTM)
-0.3
ROE
-159.7%
Margen de Beneficio Neto
—
PASG Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$4.56
Capitalización Bursátil
$15M
P/E (TTM)
-0.3
BPA (TTM)
$-14.35
Ingresos (TTM)
—
Rendimiento div.
—
ROE
-159.7%
Deuda/Capital
—
Rango 52S
$3 – $20
PASG Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
—
BPA
$-14.35
2020-12-31
→
2025-12-31
Flujo de caja libre
—
Márgenes
—
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
PASG
Mediana de Pares
P/E (TTM)
-0.3
—
P/B (P/C)
0.8
2.0
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
PASG
Mediana de Pares
ROA
-55.3%
-102.4%
ROE
-159.7%
-150.9%
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
PASG
Mediana de Pares
Current Ratio (Ratio corriente)
2.1
3.5
Quick Ratio (Ratio Rápido)
2.0
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
PASG
Mediana de Pares
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
PASG
Mediana de Pares
PASG Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
9 analistas
- Compra fuerte 2 22,2%
- Compra 4 44,4%
- Mantener 3 33,3%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
2 analistas · 2026-08-14
Mediana
$15.50
← Por Debajo de Todos los Objetivos
$4.56
Mín
$8.00
Máx
$23.00
Objetivo mediano
$15.50
+239,9%
Objetivo medio
$15.50
+239,9%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
0.15%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 30 de junio de 2026 | $-2.44 | $-2.70 | 0.26% |
| 31 de marzo de 2026 | $-2.16 | $-2.85 | 0.69% |
| 31 de diciembre de 2025 | $-3.95 | $-2.62 | -1.3% |
| 30 de septiembre de 2025 | $-2.44 | $-2.86 | 0.42% |
| 30 de junio de 2025 | $-2.96 | $-4.13 | 1.2% |
| 31 de marzo de 2025 | $-5.00 | $-4.69 | -0.31% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| PASG | $38M | -0.8 | — | — | -159.7% | — |
| KTTA | — | — | — | — | — | — |
| BCDA | $13M | — | -87.8% | — | 1660.5% | — |
| AIXC | — | -0.3 | — | — | — | — |
| SNTI | — | -0.4 | -40.2% | — | — | — |
| INTS | $1M | -0.0 | — | — | -165.1% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 12
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| R&D Expense | $23M | $40M | $61M | · | · | · | $3M | |
| SG&A Expense | $20M | $25M | $42M | $49M | $60M | $30M | $7M | |
| Operating Income | $-49M | $-70M | $-108M | $-138M | $-186M | $-113M | $-37M | |
| Interest Income | · | · | · | · | $343.0K | $670.0K | $696.0K | |
| Other Non-op | $4M | $6M | $6M | $2M | · | · | · | |
| Income Tax | $0 | $0 | · | · | · | · | · | |
| Net Income | $-46M | $-65M | $-102M | $-136M | $-185M | $-112M | $-46M | |
| EPS (Basic) | $-14.35 | $-21.04 | $-1.86 | $-2.50 | $-3.48 | $-2.91 | · | |
| EPS (Diluted) | $-14.35 | $-21.04 | $-1.86 | $-2.50 | $-3.48 | $-2.91 | · | |
| Shares (Basic) | 3,172,870 | 3,078,665 | 54,743,490 | 54,429,023 | 53,343,959 | 38,615,967 | · | |
| Shares (Diluted) | 3,172,870 | 3,078,665 | 54,743,490 | 54,429,023 | 53,343,959 | 38,615,967 | · | |
| EBITDA | $-49M | $-67M | $-105M | $-135M | $-184M | $-112M | · |
Balance general 21
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $46M | $38M | $22M | $35M | $129M | $135M | $159M | |
| Prepaid Expense | $629.0K | $838.0K | $923.0K | $926.0K | $2M | $1M | $156.0K | |
| Current Assets | $48M | $79M | $118M | $197M | $325M | $317M | $166M | |
| PP&E (Net) | $4M | $9M | $15M | $23M | $24M | $3M | $1M | |
| PP&E (Gross) | $8M | $19M | $23M | $28M | $26M | $4M | · | |
| Accum. Depreciation | $4M | $10M | $7M | $5M | $2M | $934.0K | · | |
| Other Non-current Assets | $244.0K | $463.0K | $433.0K | $4M | $6M | $8M | $12M | |
| Total Assets | $62M | $102M | $151M | $244M | $355M | $328M | $179M | |
| Accounts Payable | $1M | $742.0K | $1M | $4M | $9M | $5M | $629.0K | |
| Current Liabilities | $23M | $19M | $16M | $18M | $29M | $21M | $4M | |
| Capital Leases | $20M | $22M | $23M | $24M | · | · | · | |
| Deferred Tax | $3M | $4M | $6M | $8M | $1M | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | $41.0K | $76.0K | |
| Total Liabilities | $44M | $41M | $39M | $42M | $36M | $23M | $4M | |
| Common Stock | · | $6.0K | $5.0K | $5.0K | $5.0K | $4.0K | · | |
| Paid-in Capital | $724M | $720M | $706M | $695M | $675M | $476M | $2M | |
| Retained Earnings | $-705M | $-659M | $-594M | $-492M | $-356M | $-171M | $-59M | |
| AOCI | · | $8.0K | $-43.0K | $-966.0K | $-413.0K | $-12.0K | · | |
| Stockholders' Equity | $19M | $61M | $111M | $201M | $319M | $305M | $-56M | |
| Liabilities + Equity | $62M | $102M | $151M | $244M | $355M | $328M | $179M | |
| Shares Outstanding | 3,182,810 | 3,161,503 | 54,944,130 | 54,614,690 | 54,244,996 | 45,614,807 | 4,293,039 |
Flujo de Efectivo 11
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $728.0K | $3M | $4M | $4M | $2M | $800.0K | $134.0K | |
| Stock-based Comp | $3M | $6M | $11M | $19M | $33M | $15M | $1M | |
| Other Non-cash | $10M | $8M | $9M | $-5M | $24M | $16M | · | |
| Operating Cash Flow | $-32M | $-48M | $-78M | $-118M | $-127M | $-81M | $-40M | |
| CapEx | · | $34.0K | · | · | · | · | · | |
| Investing Cash Flow | $40M | $55M | $65M | $25M | $-46M | $-172M | $-2M | |
| Stock Issued | · | · | · | · | $166M | $228M | · | |
| Net Stock Activity | · | · | · | · | $166M | $228M | · | |
| Financing Cash Flow | $23.0K | $9M | $135.0K | $-1M | $167M | $229M | $176M | |
| Net Change in Cash | $9M | $16M | $-13M | $-94M | $-6M | $-24M | $134M | |
| Taxes Paid | $0 | $0 | · | · | · | · | · |
Rentabilidad 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| ROA | -55.3% | -51.2% | -51.8% | -45.5% | -54.3% | -44.3% | · | |
| ROE | -159.7% | -96.7% | -85.9% | -63.9% | -54.4% | -34.9% | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 4.1 | 7.2 | 10.7 | 11.0 | 15.0 | · | |
| Quick Ratio | 2.0 | 1.9 | 1.3 | 1.9 | 4.4 | 6.4 | · |
Valoración (TTM) 7
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-46M | $-65M | $-102M | $-136M | $-185M | $-112M | · | |
| Market Cap | $38M | $704M | $1.11B | $1.51B | $6.89B | $23.33B | · | |
| P/E | -0.8 | -0.5 | -10.9 | -11.0 | -36.5 | -175.7 | · | |
| P/B | 2.0 | 11.5 | 10.0 | 7.5 | 21.6 | 76.6 | · | |
| P / Tangible Book | 2.0 | 11.5 | 10.0 | 7.5 | 21.6 | 76.6 | · | |
| P / Cash Flow | -1.2 | -14.7 | -14.2 | -12.8 | -54.3 | -289.7 | · | |
| Earnings Yield | -121.6% | -185.5% | -9.2% | -9.1% | -2.7% | -0.57% | · |
Estado de resultados 10
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $3M | $4M | $5M | $4M | $6M | $8M | $10M | $9M | $10M | $12M | · | · | · | · | · | · | |
| SG&A Expense | $7M | $5M | $5M | $4M | $5M | $6M | $5M | $7M | $7M | $7M | $6M | $8M | $8M | $19M | $11M | $11M | |
| Operating Income | $-8M | $-8M | $-14M | $-9M | $-10M | $-16M | $-14M | $-21M | $-17M | $-18M | $-18M | $-29M | $-25M | $-36M | $-28M | $-28M | |
| Other Non-op | $451.0K | $688.0K | $865.0K | $906.0K | $949.0K | $1M | $2M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | · | · | |
| Net Income | $-8M | $-8M | $-13M | $-8M | $-9M | $-15M | $-13M | $-19M | $-16M | $-17M | $-17M | $-27M | $-24M | $-34M | $-27M | $-27M | |
| EPS (Basic) | $-2.44 | $-2.36 | $-8.70 | $-2.44 | $-2.96 | $-4.87 | $-9.50 | $-6.15 | $-5.09 | $-0.30 | $-0.30 | $-0.49 | $-0.44 | $-0.63 | $-0.49 | $-0.49 | |
| EPS (Diluted) | $-2.44 | $-2.36 | $-8.70 | $-2.44 | $-2.96 | $-4.87 | $-9.50 | $-6.15 | $-5.09 | $-0.30 | $-0.30 | $-0.49 | $-0.44 | $-0.63 | $-0.49 | $-0.49 | |
| Shares (Basic) | 3,208,744 | 3,205,866 | -65,284,764 | 3,178,710 | 3,168,933 | 3,163,914 | -59,505,994 | 3,146,582 | 3,142,537 | 56,295,540 | -109,348,536 | 54,789,410 | 54,683,817 | 54,618,799 | -108,706,991 | 54,473,945 | |
| Shares (Diluted) | 3,208,744 | 3,205,866 | -65,284,764 | 3,178,710 | 3,168,933 | 3,163,914 | -59,505,994 | 3,146,582 | 3,142,537 | 56,295,540 | -109,348,536 | 54,789,410 | 54,683,817 | 54,618,799 | -108,706,991 | 54,473,945 | |
| EBITDA | $-8M | $-8M | · | $-8M | $-10M | $-16M | · | $-20M | $-17M | $-17M | · | $-28M | $-24M | $-35M | · | $-28M |
Balance general 21
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $24M | $33M | $46M | $53M | $58M | $63M | $38M | $32M | $25M | $37M | $22M | $34M | $30M | $33M | $35M | $63M | |
| Prepaid Expense | $768.0K | $682.0K | $629.0K | $2M | $1M | $2M | $838.0K | $1M | $1M | $2M | $923.0K | $1M | $1M | $2M | $926.0K | $2M | |
| Current Assets | $25M | $35M | $48M | $56M | $60M | $67M | $79M | $87M | $95M | $108M | $118M | $136M | $154M | $172M | $197M | $223M | |
| PP&E (Net) | · | $826.0K | $4M | $5M | $5M | $6M | $9M | $10M | $13M | $14M | $15M | $16M | $20M | $22M | $23M | $23M | |
| PP&E (Gross) | · | $3M | $8M | $9M | $9M | $9M | $19M | $19M | $22M | $23M | $23M | $22M | $27M | $28M | $28M | $27M | |
| Accum. Depreciation | · | $2M | $4M | $4M | $4M | $3M | $10M | $9M | $9M | $8M | $7M | $6M | $7M | $6M | $5M | $4M | |
| Other Non-current Assets | · | $244.0K | $244.0K | $270.0K | $270.0K | $274.0K | $463.0K | $463.0K | $516.0K | $662.0K | $433.0K | $433.0K | $433.0K | $433.0K | $4M | $5M | |
| Total Assets | $25M | $36M | $62M | $74M | $79M | $86M | $102M | $112M | $125M | $141M | $151M | $169M | $194M | $213M | $244M | $270M | |
| Accounts Payable | $902.0K | $1M | $1M | $952.0K | $2M | $1M | $742.0K | $1M | $621.0K | $2M | $1M | $3M | $3M | $3M | $4M | $5M | |
| Current Liabilities | $21M | $20M | $23M | $22M | $20M | $18M | $19M | $17M | $12M | $13M | $16M | $20M | $20M | $17M | $18M | $22M | |
| Capital Leases | · | $5M | $20M | $21M | $21M | $21M | $22M | $22M | $22M | $23M | $23M | $23M | $23M | $24M | $24M | $24M | |
| Deferred Tax | · | · | $3M | · | · | · | $4M | · | · | · | $6M | · | · | · | $8M | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | · | $2M | · | · | |
| Total Liabilities | $21M | $25M | $44M | $43M | $41M | $39M | $41M | $39M | $35M | $36M | $39M | $43M | $43M | $43M | $42M | $46M | |
| Common Stock | · | · | · | · | · | $6.0K | · | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | |
| Paid-in Capital | $725M | $724M | $724M | $723M | $722M | $721M | $720M | $719M | $718M | $716M | $706M | $704M | $701M | $698M | $695M | $691M | |
| Retained Earnings | $-720M | $-712M | $-705M | $-692M | $-684M | $-675M | $-659M | $-647M | $-627M | $-611M | $-594M | $-578M | $-551M | $-527M | $-492M | $-465M | |
| AOCI | · | · | · | · | · | · | $8.0K | $32.0K | $-67.0K | $-69.0K | $-43.0K | $-192.0K | $-340.0K | $-427.0K | $-966.0K | $-1M | |
| Stockholders' Equity | $4M | $12M | $19M | $31M | $38M | $47M | $61M | $73M | $91M | $105M | $111M | $126M | $150M | $170M | $201M | $224M | |
| Liabilities + Equity | $25M | $36M | $62M | $74M | $79M | $86M | $102M | $112M | $125M | $141M | $151M | $169M | $194M | $213M | $244M | $270M | |
| Shares Outstanding | 3,217,810 | 3,207,810 | 3,182,810 | 3,178,710 | 3,178,710 | 62,148,274 | 3,161,503 | 61,767,286 | 61,754,786 | 61,611,796 | 54,944,130 | 54,812,972 | 54,745,680 | 54,626,690 | 54,614,690 | 54,546,596 |
Flujo de Efectivo 7
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $25.0K | $129.0K | $127.0K | $200.0K | $200.0K | $201.0K | $675.0K | $800.0K | $800.0K | $806.0K | $743.0K | $1M | $1M | $978.0K | $996.0K | $900.0K | |
| Stock-based Comp | $525.0K | $556.0K | $609.0K | $611.0K | $923.0K | $858.0K | $1M | $1M | $2M | $2M | $2M | $3M | $4M | $3M | $3M | $3M | |
| Other Non-cash | · | $-6M | · | · | · | $499.0K | · | · | · | $-5M | · | · | · | $8M | · | · | |
| Operating Cash Flow | $-9M | $-13M | $-6M | $-5M | $-6M | $-14M | $-8M | $-7M | $-13M | $-19M | $-20M | $-19M | $-17M | $-22M | $-24M | $-23M | |
| Investing Cash Flow | $0 | $20.0K | $0 | $0 | $585.0K | $40M | $14M | $15M | $1M | $25M | $8M | $22M | $14M | $21M | $-3M | $-5M | |
| Financing Cash Flow | · | · | $9.0K | $0 | · | · | $47.0K | $0 | $85.0K | $9M | $46.0K | $0 | · | · | $-588.0K | $-408.0K | |
| Net Change in Cash | $-9M | $-13M | $-6M | $-5M | $-6M | $26M | $5M | $8M | $-12M | $15M | $-12M | $3M | $-3M | $-1M | $-28M | $-29M |
Rentabilidad 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -15.0% | -12.3% | · | -8.3% | -9.2% | -13.6% | · | -13.8% | -10.0% | -9.4% | · | -12.3% | -9.7% | -12.6% | · | -8.1% | |
| ROE | -36.6% | -25.9% | · | -14.9% | -14.6% | -20.3% | · | -19.4% | -13.3% | -12.1% | · | -15.5% | -12.0% | -15.2% | · | -9.1% |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | 1.7 | · | 2.5 | 3.0 | 3.7 | · | 5.1 | 7.7 | 8.4 | · | 6.9 | 7.7 | 10.0 | · | 10.3 | |
| Quick Ratio | 1.2 | 1.7 | · | 2.4 | 2.9 | 3.6 | · | 1.9 | 2.0 | 2.9 | · | 1.7 | 1.5 | 1.9 | · | 2.9 |
Valoración (TTM) 7
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-33M | $-40M | · | $-52M | $-60M | $-67M | · | $-79M | $-84M | $-102M | · | $-112M | $-124M | $-143M | · | $-156M | |
| Market Cap | $16M | $25M | · | $26M | $25M | $439M | · | $865M | $981M | $1.66B | · | $721M | $1.03B | $1.05B | · | $1.36B | |
| P/E | -0.5 | -0.6 | · | -0.7 | -0.6 | -0.6 | · | -1.2 | -2.5 | -14.5 | · | -6.4 | -8.2 | -7.3 | · | -8.7 | |
| P/B | 3.5 | 2.1 | · | 0.8 | 0.7 | 9.4 | · | 11.9 | 10.8 | 15.9 | · | 5.7 | 6.8 | 6.1 | · | 6.1 | |
| P / Tangible Book | 3.5 | 2.1 | · | 0.8 | 0.7 | 9.4 | · | 11.9 | 10.8 | 15.9 | · | 5.7 | 6.8 | 6.1 | · | 6.1 | |
| P / Cash Flow | · | -1.9 | · | · | · | -31.7 | · | · | · | -87.9 | · | · | · | -46.6 | · | · | |
| Earnings Yield | -209.0% | -160.9% | · | -146.9% | -180.6% | -167.0% | · | -85.9% | -39.8% | -6.9% | · | -15.6% | -12.2% | -13.8% | · | -11.5% |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Beneficio neto | $-46M | $-65M | $-102M | $-136M | $-185M |
| EPS Diluido | $-14.35 | $-21.04 | $-1.86 | $-2.50 | $-3.48 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio corriente | 2.1 | 4.1 | 7.2 | 10.7 | 11.0 |
| Ratio Rápido | 2.0 | 1.9 | 1.3 | 1.9 | 4.4 |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 33 declarantes · $11.6M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 8 (-1 vs trimestre anterior) | 9 (+3 vs trimestre anterior) | 5 (-1 vs trimestre anterior) | 7 (+5 vs trimestre anterior) | +2.6M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| CITADEL ADVISORS LLC | $4 305 120 | 2 885 712 | 37,04% | Acciones |
| Lynx1 Capital Management LP | $3 287 942 | 673 759 | 28,29% | Acciones |
| New Leaf Venture Partners, L.L.C. | $702 031 | 87 426 | 6,04% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $556 144 | 113 964 | 4,78% | Acciones |
| Balyasny Asset Management L.P. | $522 282 | 107 025 | 4,49% | Acciones |
| Ikarian Capital, LLC | $485 643 | 99 517 | 4,18% | Acciones |
| Yiheng Capital Management, L.P. | $420 153 | 86 097 | 3,61% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $233 713 | 47 892 | 2,01% | Acciones |
| VANGUARD GROUP INC | $207 409 | 17 577 | 1,78% | Acciones |
| Erste Asset Management GmbH | $197 225 | 40 665 | 1,70% | Acciones |
| Verdad Advisers, LP | $149 953 | 30 728 | 1,29% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $144 751 | 29 656 | 1,25% | Acciones |
| BOOTHBAY FUND MANAGEMENT, LLC | $138 782 | 28 439 | 1,19% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $83 199 | 17 049 | 0,72% | Acciones |
| DELTEC ASSET MANAGEMENT LLC | $73 200 | 15 000 | 0,63% | Acciones |
| Fiduciary Trust Co | $52 460 | 10 750 | 0,45% | Acciones |
| GTS SECURITIES LLC | $48 800 | 10 000 | 0,42% | Acciones |
| BlackRock, Inc. | $4 748 | 973 | 0,04% | Acciones |
| UBS Group AG | $3 318 | 680 | 0,03% | Acciones |
| Vanguard Global Advisers, LLC | $3 113 | 638 | 0,03% | Acciones |
| BARCLAYS PLC | $1 035 | 212 | 0,01% | Acciones |
| SBI Securities Co., Ltd. | $825 | 169 | 0,01% | Acciones |
| WELLS FARGO & COMPANY/MN | $561 | 115 | 0,00% | Acciones |
| MORGAN STANLEY | $244 | 50 | 0,00% | Acciones |
| ACADIAN ASSET MANAGEMENT LLC | $109 | 22 496 | 0,00% | Acciones |
| JPMORGAN CHASE & CO | $73 | 15 | 0,00% | Acciones |
| OSAIC HOLDINGS, INC. | $73 | 15 | 0,00% | Acciones |
| HRT FINANCIAL LP | $62 | 12 712 | 0,00% | Acciones |
| LRI Investments, LLC | $59 | 12 | 0,00% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $59 | 12 | 0,00% | Acciones |
| HARBOUR INVESTMENTS, INC. | $15 | 3 | 0,00% | Acciones |
| CWM, LLC | $8 | 1 | 0,00% | Acciones |
| TSFG, LLC | $0 | 5 | 0,00% | Acciones |
Informantes de la empresa 25 insiders · 13 directivos · 11 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| William Chou | President and CEO | 15 de marzo de 2023 A | — | 0 | 0 | $0 |
| Bruce A Goldsmith | CEO and President | 27 de mayo de 2022 A | 15 983 | 0 | 0 | $0 |
| Kathleen Borthwick | SVP, Interim CFO | 31 de diciembre de 2023 M | 25 936 | 0 | 0 | $0 |
| Simona King | Chief Financial Officer | 28 de julio de 2023 M | 23 994 | 0 | 0 | $0 |
| Richard Steven Morris | Chief Financial Officer | 21 de mayo de 2021 P | 5 454 | 0 | 0 | $0 |
| Jill M. Quigley | Chief Operating Officer | 8 de diciembre de 2021 M | 368 754 | 0 | 0 | $0 |
| Mark S Forman | Chief Medical Officer | 31 de diciembre de 2023 M | 45 269 | 0 | 0 | $0 |
| Edgar B. Cale | GC & Corporate Secretary | 31 de diciembre de 2023 M | 45 995 | 0 | 0 | $0 |
| Alexandros Fotopoulos | Chief Technical Officer | 15 de junio de 2023 M | 28 693 | 0 | 0 | $0 |
| Monika Maria Toernsen | Chief Commercial Officer | 15 de septiembre de 2022 M | 3 319 | 0 | 0 | $0 |
| Eliseo Oreste Salinas | Chief Res. & Develop Officer | 22 de marzo de 2021 A | — | 0 | 0 | $0 |
| Gary Romano | Chief Medical Officer | 15 de marzo de 2021 M | 0 | 0 | 0 | $0 |
| Stephen P Squinto | Head of Research and Dev | 27 de febrero de 2020 A | — | 0 | 0 | $0 |
| Dolan Sondhi | Consejero | 27 de julio de 2023 A | — | 0 | 0 | $0 |
| Derrell Porter | Consejero | 25 de mayo de 2023 A | — | 0 | 0 | $0 |
| Sandip Kapadia | Consejero | 25 de mayo de 2023 A | 0 | 0 | 0 | $0 |
| Thomas Woiwode | Consejero | 25 de mayo de 2023 A | 933 352 | 0 | 0 | $0 |
| Saqib Islam | Consejero | 25 de mayo de 2023 A | 5 000 | 0 | 0 | $0 |
| Athena Countouriotis | Consejero | 25 de mayo de 2023 A | 18 900 | 0 | 0 | $0 |
| Michael E. Kamarck | Consejero | 25 de mayo de 2023 A | — | 0 | 0 | $0 |
| Patrick J. Heron | Consejero | 3 de marzo de 2020 C | 5 009 219 | 0 | 0 | $0 |
| Thomas Richard Kassberg | — | 19 de mayo de 2026 A | — | 0 | 0 | $0 |
| Maxine Gowen | — | 19 de mayo de 2026 A | — | 0 | 0 | $0 |
| Liam Ratcliffe | — | 27 de mayo de 2021 A | 2 800 | 0 | 0 | $0 |
| Tadataka Yamada | — | 27 de mayo de 2021 A | 656 149 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 4 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Lynx1 Capital Management LP, Weston Nichols | 2 de julio de 2026 | 21,00% | Presentación inicial | M&A / venta | SEC |
| ORBIMED ADVISORS LLC, ORBIMED CAPITAL GP VII LLC ×10 presentaciones | 24 de julio de 2025 | 4,25% | Enmienda | — | SEC |
| Versant Venture Capital VI, L.P., Versant Ventures VI GP, L.P., Versant Ventures VI GP-GP, LLC ×4 presentaciones | 9 de agosto de 2024 | — | Presentación inicial | — | SEC |
| Frazier Life Sciences IX, L.P., FHMLS IX, L.P., FHMLS IX, L.L.C., James N. Topper, Patrick J. Heron ×4 presentaciones | 15 de junio de 2023 | — | Presentación inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 4 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| DCOR · Dimensional ETF Trust | 0,00% | 1 263 NS | 30 de abril de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 35 200 SH | 8 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 78 764 SH | 8 de agosto de 2026 | Diario |
| DFAC · Dimensional ETF Trust | 0,00% | 792 NS | 30 de abril de 2026 | N-PORT |